Issues in clinical trial design I: Use of natural history controls. A protagonist view

Neurology

Volumn 47, Issue 4 SUPPL., 1996, Pages

  Munsat, Theodore L ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; STEROID;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DATA BASE; DRUG EFFICACY; DUCHENNE MUSCULAR DYSTROPHY; FUNCTIONAL ASSESSMENT; HUMAN; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; PHASE 2 CLINICAL TRIAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0029807649     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.47.4_suppl_2.96s     Document Type: Article

References (10)

1. Festoff BW, Smith RA, Melmed S, et al. Tufts Quantitative Neuromuscular Exam (TQNE) and amyotrophic lateral sclerosis (ALS) trials in the recombinant age [abstract]. Ann Neurol 1988:24;138-139.
2. National TRH Study Group. Multicenter controlled trial: no effect of alternate day 5 mg/kg subcutaneous thyrotropin releasing hormone (TRH) on isometric-strength decrease in amyotrophic lateral sclerosis [abstract]. Neurology 1989; 39(suppl 1):32.
3. Ellison GW, Mickey MR, Myers LW. Alternatives to randomized clinical trials. Neurology 1988;38(suppl 2):73-75.
4. Andres PL, Hedlund W, Finison L, Conlon T, Felmus M, Munsat TL. Quantitative motor assessment in amyotrophic lateral sclerosis. Neurology 1986;36:405-408.
5. Edwards RHT, Chapman SJ, Newham DJ, Jones DA. Practical analysis of variability of muscle function measurements in Duchenne muscular dystrophy. Muscle Nerve 1987;10:6-14.
6. Juergens SM, Kurland LT, Okazaki H, Mulder DW. ALS in Rochester, Minnesota, 1925-1977. Neurology 1980;30:463-470.
7. Gehan EA, Freirich EJ. Non-randomized control in cancer clinical trials. N Engl J Med 1974;290:198-203.
8. Mendell JR, Province MA, Moxley RI III, et al. Clinical investigation of Duchenne muscular dystrophy: a methodology for therapeutic trials based on natural history controls. Arch Neurol 1987;44:812-817.
9. Brooke MH, Finichel GM, Griggs RC, et al. Clinical investigation of Duchenne muscular dystrophy: interesting results in a trial of prednisone. Arch Neurol 1987;44:812-817.
10. Griggs RC, Moxley RT, Mendell JR, et al. Prednisone in Duchenne dystrophy: a randomized, controlled trial defining the time course and dose response. Arch Neurol 1991;48:383-388.